1 results match your criteria: "Charles University in Prague and Teaching Hospital Motol[Affiliation]"
Does asymptomatic carriage of FV Leiden and FII prothrombin mutations in heterozygous configuration pose an increased risk of thrombembolic complications in the course of pregnancy, labor and puerperium?
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
June 2014
Department of Obstetrics and Gynaecology, 2nd Faculty of Medicine, Charles University in Prague and Teaching Hospital Motol, Prague, Czech Republic.
Objective: To evaluate the course of pregnancy and puerperium in asymptomatic carriers of FV Leiden and FII prothrombin mutation in heterozygous configuration in terms of risk of thrombembolic disease (TED) and late pregnancy complications. To evaluate whether global prophylactic LMWH administration during pregnancy benefits these women.
Methods: We monitored the incidence of thrombembolic events and severe late pregnancy complications in 473 asymptomatic carriers of FV Leiden and FII prothrombin mutation in heterozygous configuration.